Home > Financial Ratios > SOLARA ACTIVE PHARMA SCIENCES

SOLARA ACTIVE PHARMA SCIENCES
Core EBITDA Growth

    Back to All Ratios
SOLARA ACTIVE PHARMA SCIENCES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SOLARA ACTIVE PHARMA SCIENCES
Please provide your vote to see the results

SOLARA ACTIVE PHARMA SCIENCES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) -157.4156.45-75.8944.4923.06

What is the latest Core EBITDA Growth ratio of SOLARA ACTIVE PHARMA SCIENCES ?

The latest Core EBITDA Growth ratio of SOLARA ACTIVE PHARMA SCIENCES is -157.41 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar2024-157.41
Mar202356.45
Mar2022-75.89
Mar202144.49
Mar202023.06

How is Core EBITDA Growth of SOLARA ACTIVE PHARMA SCIENCES Trending?

Years Core EBITDA Growth % Change
Mar2024 -157.41
Negative
Mar2023 56.45
Positive
Mar2022 -75.89
Negative
Mar2021 44.49
92.93
Mar2020 23.06 -

Other Financial Ratios of SOLARA ACTIVE PHARMA SCIENCES


Compare Core EBITDA Growth ratio of peers of SOLARA ACTIVE PHARMA SCIENCES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SOLARA ACTIVE PHARMA SCIENCES ₹2,508.4 Cr -0.9% -16.3% 45.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,827.0 Cr -2% -0.8% 16.6% Stock Analytics
DIVIS LABORATORIES ₹157,931.0 Cr -2.7% 3.5% 66.7% Stock Analytics
CIPLA ₹117,322.0 Cr 0.7% 1.4% 3.7% Stock Analytics
DR REDDYS LABORATORIES ₹101,116.0 Cr 0.1% -8.5% 0.7% Stock Analytics
ZYDUS LIFESCIENCES ₹94,752.0 Cr -0.9% -1% 24% Stock Analytics


SOLARA ACTIVE PHARMA SCIENCES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SOLARA ACTIVE PHARMA SCIENCES

-0.9%

-16.3%

45.8%

SENSEX

-2.9%

-0.1%

6.8%


You may also like the below Video Courses